Abbott has reported late-breaking five-year positive data from a trial of its Amplatzer Amulet left atrial appendage (LAA) occluder for reducing the long-term need for blood-thinning medication in ...
partial cardiac denervation helped reduce the risk of postoperative atrial fibrillation (Afib) in a randomized trial. (JAMA Cardiology) Five-year results from the Amulet IDE trial suggested ...
CEO Robert Ford also plans to expand sales of the company’s Lingo over-the-counter glucose sensors after a limited rollout.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback